4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-046012
Chief Medical Officer sold 5,000 shares at an average $40.39 ($201,931)
- Chief Medical Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Pang Phillip · Chief Medical Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-07 | Exercise or conversion : show line 1 in the form | +5,000 | $5.18 | $25,875 | 114,277 | D |
| 2021-07-07 | Sale : show line 2 in the form | −3,505 | $40.16 | $140,772 | 110,772 | D |
| 2021-07-07 | Sale : show line 3 in the form | −1,495 | $40.91 | $61,159 | 109,277 | D |
| Open-market sales · 5,000 sh · avg $40.39 · $201,931 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-07-07 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −5,000 | 57,129 | D |
Loading xslF345X03/doc4.xml…